Immediate Impact
1 from Science/Nature 69 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
2022 Standout
Works of B.G. Miller being referenced
Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
1997 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| B.G. Miller | 609 | 63 | 23 | 118 | 117 | 15 | 704 | |
| Dennis Sweitzer | 652 | 57 | 95 | 140 | 192 | 13 | 801 | |
| A. Torbeyns | 527 | 44 | 52 | 85 | 86 | 14 | 649 | |
| Joseph Stringfellow | 472 | 39 | 60 | 89 | 128 | 19 | 657 | |
| Eva Kohegyi | 416 | 68 | 57 | 147 | 150 | 14 | 727 | |
| Rikus Knegtering | 574 | 79 | 22 | 171 | 59 | 18 | 724 | |
| Seung-Hee Hong | 430 | 39 | 40 | 223 | 64 | 9 | 819 | |
| Bin Fang | 575 | 33 | 58 | 141 | 86 | 11 | 812 | |
| Amy J. Kuntz | 568 | 47 | 24 | 125 | 153 | 9 | 757 | |
| I. Kurzthaler | 446 | 70 | 74 | 93 | 120 | 30 | 679 | |
| Matthew A. Fuller | 551 | 130 | 80 | 89 | 161 | 48 | 793 |
All Works
Loading papers...